Daratumumab, lenalidomide, dexamethasone, DARZALEX [daratumumab], TECVAYLI [teclistamab], TALVEY [talquetamab] clinical trials

Personalising treatment for myeloma patients based on initial response to NHS treatment and their overall fitness level

This study is for myeloma patients who are newly diagnosed and can't have a stem cell transplant. It aims to personalise treatment based on their response to initial NHS therapy and their fitness level, to see if this improves outcomes.